Cargando…

Signal transducer and activator of transcription 3 in myeloid-derived suppressor cells: an opportunity for cancer therapy

Cancer progression is in part determined by interactions between cancer cells and stromal cells in the tumor microenvironment (TME). The identification of cytotoxic tumor-infiltrating lymphocytes has instigated research into immune stimulating cancer therapies. Although a promising direction, immuno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dufait, Inès, Van Valckenborgh, Els, Menu, Eline, Escors, David, De Ridder, Mark, Breckpot, Karine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5173167/ https://www.ncbi.nlm.nih.gov/pubmed/27029037 http://dx.doi.org/10.18632/oncotarget.8311

Ejemplares similares

Ex vivo generation of myeloid-derived suppressor cells that model the tumor immunosuppressive environment in colorectal cancer
por: Dufait, Inès, et al.
Publicado: (2015)

Perforin and Granzyme B Expressed by Murine Myeloid-Derived Suppressor Cells: A Study on Their Role in Outgrowth of Cancer Cells
por: Dufait, Inès, et al.
Publicado: (2019)

Assessing T-cell responses in anticancer immunotherapy: Dendritic cells or myeloid-derived suppressor cells?
por: Escors, David, et al.
Publicado: (2013)

Myeloid-Derived Suppressor Cells as Therapeutic Target in Hematological Malignancies
por: De Veirman, Kim, et al.
Publicado: (2014)

The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells
por: Wang, Jinheng, et al.
Publicado: (2015)

The prognostic value and therapeutic targeting of myeloid-derived suppressor cells in hematological cancers
por: Fan, Rong, et al.
Publicado: (2022)

Multiple myeloma induces Mcl-1 expression and survival of myeloid-derived suppressor cells
por: De Veirman, Kim, et al.
Publicado: (2015)

Retroviral and Lentiviral Vectors for the Induction of Immunological Tolerance
por: Dufait, Inès, et al.
Publicado: (2012)

Granulocytic myeloid-derived suppressor cells promote angiogenesis in the context of multiple myeloma
por: Binsfeld, Marilène, et al.
Publicado: (2016)

Understanding the hypoxic niche of multiple myeloma: therapeutic implications and contributions of mouse models
por: Hu, Jinsong, et al.
Publicado: (2012)

Unraveling the Effects of a Talimogene Laherparepvec (T-VEC)-Induced Tumor Oncolysate on Myeloid Dendritic Cells
por: Tijtgat, Jens, et al.
Publicado: (2021)

Novel strategies to target the ubiquitin proteasome system in multiple myeloma
por: Lub, Susanne, et al.
Publicado: (2015)

Epigenetic Modulating Agents as a New Therapeutic Approach in Multiple Myeloma
por: Maes, Ken, et al.
Publicado: (2013)

Preclinical Evaluation of Invariant Natural Killer T Cells in the 5T33 Multiple Myeloma Model
por: Nur, Haneen, et al.
Publicado: (2013)

The Effects of Forodesine in Murine and Human Multiple Myeloma Cells
por: Bieghs, Liesbeth, et al.
Publicado: (2010)

Cell and Tissue Gene Targeting with Lentiviral Vectors
por: Escors, David, et al.
Publicado: (2012)

Radioresistance of Human Cancers: Clinical Implications of Genetic Expression Signatures
por: de Mey, Sven, et al.
Publicado: (2021)

In vivo treatment with epigenetic modulating agents induces transcriptional alterations associated with prognosis and immunomodulation in multiple myeloma
por: Maes, Ken, et al.
Publicado: (2014)

Oncolytic Herpes Simplex Virus Type 1 Induces Immunogenic Cell Death Resulting in Maturation of BDCA-1(+) Myeloid Dendritic Cells
por: Kalus, Philipp, et al.
Publicado: (2022)

Th17/Treg imbalance in COPD development: suppressors of cytokine signaling and signal transducers and activators of transcription proteins
por: Silva, Larissa E. F., et al.
Publicado: (2020)

Role of non-classical MHC class I molecules in cancer immunosuppression
por: Kochan, Grazyna, et al.
Publicado: (2013)

PD1 signal transduction pathways in T cells
por: Arasanz, Hugo, et al.
Publicado: (2017)

Myeloid-Derived Suppressor Cells in Multiple Myeloma: Pre-Clinical Research and Translational Opportunities
por: Botta, Cirino, et al.
Publicado: (2014)

Extracellular vesicle cross-talk in the bone marrow microenvironment: implications in multiple myeloma
por: Wang, Jinheng, et al.
Publicado: (2016)

Histone deacetylase inhibitors in multiple myeloma
por: Deleu, Sarah, et al.
Publicado: (2009)

Miconazole inhibits signal transducer and activator of transcription 3 signaling by preventing its interaction with DNA damage‐induced apoptosis suppressor
por: Yoon, Sung‐Hoon, et al.
Publicado: (2020)

Loss-of-function of the hippo transducer TAZ reduces mammary tumor growth through a myeloid-derived suppressor cell-dependent mechanism
por: Shen, He, et al.
Publicado: (2022)

Myeloid Derived Suppressor Cells in Chronic Myeloid Leukemia
por: Giallongo, Cesarina, et al.
Publicado: (2015)

Myeloid-Derived Suppressor Cells in Sepsis
por: Lai, Dengming, et al.
Publicado: (2014)

Myeloid-Derived Suppressor Cells in Sepsis
por: Schrijver, Irene T., et al.
Publicado: (2019)

On the origin of myeloid-derived suppressor cells
por: Millrud, Camilla Rydberg, et al.
Publicado: (2016)

Myeloid-derived suppressor cells in gliomas
por: Gieryng, Anna, et al.
Publicado: (2016)

Myeloid-Derived Suppressor Cell Differentiation in Cancer: Transcriptional Regulators and Enhanceosome-Mediated Mechanisms
por: Fultang, Norman, et al.
Publicado: (2021)

Cancer-Associated Myeloid Regulatory Cells
por: De Vlaeminck, Yannick, et al.
Publicado: (2016)

Myeloid derived suppressor cells: Targets for therapy
por: Waldron, Todd J., et al.
Publicado: (2013)

Myeloid-derived suppressor cells, age and cancer
por: Bowdish, Dawn ME
Publicado: (2013)

Chemotherapeutic targeting of myeloid-derived suppressor cells
por: Alizadeh, Darya, et al.
Publicado: (2014)

Myeloid Derived Suppressor Cells: Fuel the Fire
por: Achyut, B. R., et al.
Publicado: (2014)

Myeloid-Derived Suppressor Cells in Bacterial Infections
por: Ost, Michael, et al.
Publicado: (2016)

Myeloid-Derived Suppressor Cells and Pulmonary Hypertension
por: Bryant, Andrew J., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7vg32squsb4gl3h3nhvskgda52